GJA1 and acute chest syndrome: However, there was a significant decrease (by ~30%) in the abundance of Cx43 membrane staining in cells treated with EVs, obtained during ACS episodes, compared with cells treated with EVs from subjects at baseline or controls (Figure 3A).